Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|January 28, 2022
Natural Killer Cells in the Malignant Niche of Multiple MyelomaOndrej Venglar, Julio Rodriguez Bago, Benjamin Motais, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 24, 2025
OMIP-117: 40-Parameter/37-Color Spectral Cytometry Panel for Robust Immunoprofiling of Human Lymphoid Subsets in Cancer PatientsOndrej Venglar, Eva Radova, Lucie Broskevicova, et al.
Nature Communications|November 10, 2022
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myelomaAlexander Vdovin, Tomas Jelinek, David Zihala, et al.
Haematologica|July 16, 2026
Teclistamab in relapsed/refractory Waldenstro m macroglobulinemiaMichal Kascak, Ludmila Muronova, Ondrej Venglar, et al.
British Journal of Haematology|October 9, 2023
Insight into the mechanism of CD34<sup>+</sup> cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapyOndrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, et al.
European Journal of Haematology|October 11, 2024
Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow CytometryLudmila Muronova, Ondrej Soucek, David Zihala, et al.
Hemasphere|September 25, 2025
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myelomaJuan-Jose Garces, Benjamin Diamond, Tereza Sevcikova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple MyelomaTomas Jelinek, Renata Bezdekova, David Zihala, et al.
Blood Cancer Discovery|November 14, 2025
Composition and functional state of T and NK cells in the extramedullary myeloma tumor microenvironmentAnjana Anilkumar Sithara, Veronika Kapustova, David Zihala, et al.
Pageof 2